A man on a mission to transform generic pharmaceuticals: Alvogen CEO and founder, Robert Wessman, discusses the company's growth
LONDON, Jan. 04, 2018 (GLOBE NEWSWIRE) -- The pharmaceuticals industry is going through one of its most exciting periods yet. Generic pharmaceuticals have taken off, leading to much more innovation in the market and a wave of consolidation across the US.
Keeping on top of all these changes is Robert Wessman, CEO and founder of pharmaceuticals organisation Alvogen. His knack for spotting industry developments has seen the company soar to great heights and become a pharmaceutical leader.
Wessman recently spoke to World Finance magazine, in a three-part video series, to share his knowledge - and predictions - for the pharmaceutical market.
Though only created in 2009, Alvogen has grown substantially over the years. Wessman discusses its inception in the video series; astonishingly, the vision for Alvogen was initially sketched out on a napkin. Wessman had met investors in a New York restaurant and it was the easiest way to communicate his pharmaceutical vision. They were sold.
Today, Alvogen's ability to thrive in one of the world's most competitive sectors is underpinned by its fast responses to industry movements and strong team.
Later on in the video series, Wessman gives his top tips for leadership, explaining what traits are needed in order to make a business work. He also explains why it's so important to know what you're looking for in recruitment - so as to build the perfect team.
For some of the best insights in the generics pharmaceutical industry, go to World Finance online - where the three-part video series is available:
World News Media is a leading publisher of quality financial and business magazines, which enjoys a global distribution network that includes subscriber lists of prominent decision-makers around the world.
World News Media
+44 (0)20 7553 4162
Information om Globenewswire
Følg pressemeddelelser fra Globenewswire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Globenewswire
DoubleVerify11.12.2018 18:05 | Pressemeddelelse
DoubleVerify and InMobi Unite to Combat Mobile App Fraud
Claroty11.12.2018 15:03 | Pressemeddelelse
Claroty Announces Major Enhancements to Market-Leading Industrial Cybersecurity Platform
Farmako GmbH11.12.2018 10:01 | Pressemeddelelse
Farmako: Cannabis distributor to become gateway to Europe
Graduate Management Admission Council10.12.2018 16:28 | Pressemeddelelse
The Graduate Management Admission Council Selects Three New Business Schools for Membership
CereSpir Inc.10.12.2018 15:01 | Pressemeddelelse
CERESPIR INCORPORATED and the NATIONAL NEUROSCIENCE INSTITUTE SINGAPORE Announce Positive Data Showing Beneficial Effects of CERESPIR’s Clinical Stage Compound Itanapraced in a LRRK2 Model of Parkinson’s Disease
Centrient Pharmaceuticals10.12.2018 13:31 | Pressemeddelelse
DSM Sinochem Pharmaceuticals announces its new name - Centrient Pharmaceuticals
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.Besøg vores nyhedsrum